- Home
- RNST vs MLTX Comparison
RNST vs MLTX Comparison
Compare RNST & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNST
- MLTX
- Stock Information
- Founded
- RNST 1904
- MLTX 2021
- Country
- RNST United States
- MLTX Switzerland
- Employees
- RNST N/A
- MLTX N/A
- Industry
- RNST Major Banks
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- RNST Finance
- MLTX Health Care
- Exchange
- RNST Nasdaq
- MLTX Nasdaq
- Market Cap
- RNST 2.2B
- MLTX 2.3B
- IPO Year
- RNST N/A
- MLTX N/A
- Fundamental
- Price
- RNST $33.90
- MLTX $38.60
- Analyst Decision
- RNST Buy
- MLTX Strong Buy
- Analyst Count
- RNST 6
- MLTX 8
- Target Price
- RNST $42.20
- MLTX $80.50
- AVG Volume (30 Days)
- RNST 993.9K
- MLTX 423.9K
- Earning Date
- RNST 04-22-2025
- MLTX 05-20-2025
- Dividend Yield
- RNST 2.61%
- MLTX N/A
- EPS Growth
- RNST 31.26
- MLTX N/A
- EPS
- RNST 3.20
- MLTX N/A
- Revenue
- RNST $710,248,000.00
- MLTX N/A
- Revenue This Year
- RNST $39.96
- MLTX $103.42
- Revenue Next Year
- RNST $15.28
- MLTX N/A
- P/E Ratio
- RNST $10.61
- MLTX N/A
- Revenue Growth
- RNST 15.97
- MLTX N/A
- 52 Week Low
- RNST $26.97
- MLTX $31.42
- 52 Week High
- RNST $39.63
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- RNST 61.87
- MLTX 53.31
- Support Level
- RNST $32.63
- MLTX $36.75
- Resistance Level
- RNST $34.13
- MLTX $42.90
- Average True Range (ATR)
- RNST 0.96
- MLTX 2.06
- MACD
- RNST 0.48
- MLTX 0.03
- Stochastic Oscillator
- RNST 96.34
- MLTX 58.04
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.